Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade

被引:91
作者
Budaeus, Lars [1 ,2 ]
Spethmann, Jan [1 ,2 ]
Isbarn, Hendrik [1 ,2 ]
Schmitges, Jan [2 ]
Beesch, Laura [1 ]
Haese, Alexander [1 ]
Salomon, Georg [1 ]
Schlomm, Thorsten [1 ]
Fisch, Margit [2 ]
Heinzer, Hans [1 ]
Huland, Hartwig [1 ]
Graefen, Markus [1 ]
Steuber, Thomas [1 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Prostate Canc Ctr, Martiniclin, D-20246 Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany
关键词
radical prostatectomy; PSA; stage migration; grade migration; LIFE EXPECTANCY; CLINICAL STAGE; EAU GUIDELINES; CANCER; PATHOLOGY; ANTIGEN; MEN; PREDICTION; NOMOGRAM;
D O I
10.1111/j.1464-410X.2010.09982.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
OBJECTIVE To investigate the stage migration patterns during the last decade in European men treated with radical prostatectomy (RP). PATIENTS AND METHODS Between 2000 and 2009, RP was performed in 8916 patients at a single European tertiary-care institution. Age at diagnosis, clinical and pathological data were prospectively collected, and trends and proportions of preoperative and pathological findings were analysed over time. RESULTS The median (mean) age of patients increased from 62 (62) to 63 (65) years between 2000 and 2009 (P < 0.001). When patients were stratified based on their clinical findings according to the D'Amico risk groups for disease progression, the proportion of low-risk patients dropped from 66% in 2004 to 35% (P = 0.016) in the final year of the study period. Similarly, histopathological evaluation of RP specimens showed a decrease of favourable disease (organ confinement and Gleason 3 + 3 grade) from 53 to 17% (P = 0.008). This trend was accompanied by an increase in the number of patients with non-organ-confined prostate cancer (PCa) from 19% in 2003 to 33% in 2009 (P = 0.008). The restriction of the analyses in the present study to a single tertiary-care centre could limit the generalizeability of the results. CONCLUSIONS During the last decade, we observed an inverse stage migration trend in those European patients with PCa who were treated with RP. The recorded increase in patients with non-organ-confined disease after RP could be related to changes in patient selection and the growing adoption of RP in multimodal treatment settings for locally advanced tumours as well as the availability of new treatment alternatives for low-risk disease.
引用
收藏
页码:1256 / 1261
页数:6
相关论文
共 34 条
[1]
*ABL, 2010, INV REL
[2]
Prostate cancer and the Will Rogers phenomenon [J].
Albertsen, PC ;
Hanley, JA ;
Barrows, GH ;
Penson, DF ;
Kowalczyk, PDH ;
Sanders, MM ;
Fine, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) :1248-1253
[3]
Albertsen PC, 2002, AUSTRIA J UROL, V168, P880
[4]
Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: Results of a single center between 1999 and 2002 [J].
Augustin, H ;
Hammerer, P ;
Graefen, M ;
Palisaar, R ;
Noldus, J ;
Fernandez, S ;
Huland, H .
EUROPEAN UROLOGY, 2003, 43 (02) :113-118
[5]
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy [J].
Budaeus, Lars ;
Isbarn, Hendrik ;
Schlomm, Thorsten ;
Heinzer, Hans ;
Haese, Alexander ;
Steuber, Thomas ;
Salomon, Georg ;
Huland, Hartwig ;
Graefen, Markus .
EUROPEAN UROLOGY, 2009, 56 (02) :317-324
[6]
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [J].
Cooperberg, Matthew R. ;
Broering, Jeanette M. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1117-1123
[7]
Predicting life expectancy in men with clinically localized prostate cancer [J].
Cowen, ME ;
Halasyamani, LK ;
Kattan, MW .
JOURNAL OF UROLOGY, 2006, 175 (01) :99-103
[8]
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[9]
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma [J].
Epstein, JI ;
Allsbrook, WC ;
Amin, MB ;
Egevad, LL ;
Bastacky, S ;
Beltrán, AL ;
Berner, A ;
Billis, A ;
Boccon-Gibod, L ;
Cheng, L ;
Civantos, F ;
Cohen, C ;
Cohen, MB ;
Datta, M ;
Davis, C ;
Delahunt, B ;
Delprado, W ;
Eble, JN ;
Foster, CS ;
Furusato, M ;
Gaudin, PB ;
Grignon, DJ ;
Humphrey, PA ;
Iczkowski, KA ;
Jones, EC ;
Lucia, S ;
McCue, PA ;
Nazeer, T ;
Oliva, E ;
Pan, CC ;
Pizov, G ;
Reuter, V ;
Samaratunga, H ;
Sebo, T ;
Sesterhenn, I ;
Shevchuk, M ;
Srigley, JR ;
Suzigan, S ;
Takahashi, H ;
Tamboli, P ;
Tan, PH ;
Têtu, B ;
Tickoo, S ;
Tomaszewski, JE ;
Troncoso, P ;
Tsuzuki, T ;
True, LD ;
van der Kwast, T ;
Wheeler, TM ;
Wojno, KJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1228-1242
[10]
Radical prostatectomy for clinical stage T3a disease [J].
Freedland, Stephen J. ;
Partin, Alan W. ;
Humphreys, Elizabeth B. ;
Mangold, Leslie A. ;
Walsh, Patrick C. .
CANCER, 2007, 109 (07) :1273-1278